Arcellx Correlations

ACLX Stock

USD 66.48 0.53 0.79%

The current 90-days correlation between Arcellx and Nuvalent is 0.47 (i.e., Very weak diversification). The correlation of Arcellx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Arcellx Correlation With Market

Average diversification

The correlation between Arcellx and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcellx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Arcellx Stock please use our How to Invest in Arcellx guide.

Moving together with Arcellx Stock

0.88	DNLI	Denali Therapeutics	Pair Corr
0.63	DNTH	Dianthus Therapeutics	Pair Corr
0.77	DOMH	Dominari Holdings	Pair Corr
0.69	VERA	Vera Therapeutics	Pair Corr
0.74	DTIL	Precision BioSciences	Pair Corr
0.72	VIGL	Vigil Neuroscience	Pair Corr
0.69	VINC	Vincerx Pharma	Pair Corr
0.71	VKTX	Viking Therapeutics	Pair Corr
0.76	VNDA	Vanda Pharmaceuticals	Pair Corr
0.79	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.68	VRPX	Virpax Pharmaceuticals	Pair Corr
0.83	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Arcellx Stock

0.82	DRTS	Alpha Tau Medical	Pair Corr
0.62	CDIOW	Cardio Diagnostics	Pair Corr
0.61	DMAC	DiaMedica Therapeutics	Pair Corr
0.59	SABSW	SAB Biotherapeutics	Pair Corr
0.38	VCEL	Vericel Corp Ord	Pair Corr
0.38	VCYT	Veracyte Potential Growth	Pair Corr
0.73	VRNA	Verona Pharma PLC	Pair Corr
0.68	SRZNW	Surrozen Warrant	Pair Corr
0.54	DYAI	Dyadic International	Pair Corr
0.47	VSTM	Verastem	Pair Corr
0.31	VRAX	Virax Biolabs Group	Pair Corr

Related Correlations Analysis

	NUVL	VTYX	AMLX	DAWN	BMEA
NUVL		0.35	0.55	0.77	0.77	NUVL
VTYX	0.35		0.01	0.1	0.1	VTYX
AMLX	0.55	0.01		0.77	0.46	AMLX
DAWN	0.77	0.1	0.77		0.8	DAWN
BMEA	0.77	0.1	0.46	0.8		BMEA
	NUVL	VTYX	AMLX	DAWN	BMEA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Arcellx Stock performing well and Arcellx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Arcellx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NUVL	1.81	(0.46)	0.00	(0.69)	0.00	0.00	2.60	(5.28)	11.10
VTYX	4.66	(0.05)	0.00	(0.05)	0.00	0.00	11.35	(7.53)	35.02
AMLX	4.38	0.14	0.03	0.17	5.38	(4.42)	9.49	(8.97)	33.56
DAWN	1.84	(0.20)	0.00	(0.18)	0.00	0.00	3.92	(3.46)	11.05
BMEA	3.80	(1.35)	0.00	(0.64)	0.00	0.00	5.38	(11.36)	28.29

Arcellx Corporate Management

Michael MBA	Chief Officer	Profile
Aileen Fernandes	Chief Officer	Profile
Kate Aiken	Chief Officer	Profile
Michelle Gilson	Chief Officer	Profile
Myesha Lacy	Chief Officer	Profile
Christopher MD	Chief Officer	Profile
MS JD	General Counsel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC